Marijuana Moment: Virginia’s Cannabis Sales Legalization Bill Gives An Unfair Head Start To Existing Big Businesses (Op-Ed)

[Tokeativity]

“Catching a market in motion is fundamentally harder than entering one that has not started yet.”

By Max Jackson, Cannabis Wise Guys

Imagine a race track. Five cars are already on it—tuned, tested, crewed and running laps at two hundred miles an hour. They have been on this track for years. Now imagine telling a new driver to enter that race. Not next season. Today. Except they do not have a car yet. They have not built it. They have not secured financing for the parts. Some of them have not gotten their license.

That is Virginia’s cannabis market on January 1, 2027 under a sales legalization bill that lawmakers recently sent to Gov. Abigail Spanberger (D).

The five pharmaceutical processors who currently run Virginia’s medical program will begin adult-use sales that day with inventory in their vaults, staff on payroll and retail locations already open. The independent businesses that were supposed to create competition in this market will not have broken ground.

This is not a head start. It is a structural problem disguised as a calendar date. And the reason it matters is not just that incumbents go first—it is what happens to the market while independents are still building.

Phase One: The Track Is Already Hot

When adult-use sales begin, only the five existing processors can sell. That is the math of the situation; nobody else has product. Every day the market operates with five sellers is a day where pricing is set by five companies, where retailers build purchasing relationships with five companies and where consumers form brand habits around five companies.

None of this requires bad actors. None of it is illegal. It is rational behavior in a market where the only participants are the ones who were already there.

But there is a less visible advantage compounding underneath. Those five processors are generating revenue at prices that only a market without competition can sustain. Every dollar of that revenue pays down equipment, retires debt and builds a financial cushion that did not exist before the market opened.

By the time independent competitors arrive, the incumbents’ cost structures have been subsidized by months (or years) of uncontested sales. The independent shows up with a brand-new mortgage on a brand-new facility, competing against an operator whose facility is already half paid off.

That is not a gap in quality. It is a gap in math that widens every month that Phase One continues.

Phase Two: New Stores, Same Suppliers

Retail licenses get issued. Stores open. They need product on their shelves.

Independent cultivators still do not have any. A cultivation facility takes 12 to 18 months to build. The plant itself requires four to six months from clone to a tested, packaged product that can legally sit on a dispensary shelf.

A retailer who opens in month three or month six of the market has exactly one sourcing option: the five processors. Not because they prefer them. Because nobody else has a gram to sell.

And the processors do not show up with one product. They show up with 10, 15, 20 brands—flower, concentrates, edibles, pre-rolls—plus displays, marketing support and a single point of contact who can stock an entire store in one phone call.

A new dispensary owner with rent due and shelves to fill is not comparing suppliers. They are saying yes to the only supplier who can solve their entire problem at once.

When independent cultivators eventually come online with a single strain and no marketing budget, they are not just competing against a brand. They are competing against a relationship that was built when they did not exist—a relationship where the retailer’s entire menu, supplier infrastructure and customer base was constructed around companies that showed up when nobody else could.

That relationship does not dissolve because a better product arrives. It persists because switching costs are real, because shelf space is finite, and because the retailer already knows the processor’s delivery schedule, margin structure and product consistency.

The independent offers none of that. Not because they are worse. Because they are new.

Phase Three: Merging At Full Speed

This is where the race track stops being a metaphor.

When independent cultivators finally come online—18 months to 36 months after the market opened—they are not entering a market that paused to wait for them. They are entering one that has been accelerating without them.

Pricing expectations are locked. Shelf space is committed. Wholesale relationships have a year of history behind them. Consumers already know what brands they buy.

Entering a market at rest is hard. Entering a market at speed is a fundamentally different problem. Every month the market operated without independents is a month it accelerated away from them.

The incumbents’ debt is shrinking while the independents’ debt is just beginning. The incumbents’ retail relationships are twelve months deep, while the independents have never made a delivery. The incumbents’ brands have years of consumer data, while the independents have a name nobody recognizes.

The independent cultivator’s first harvest is not arriving into a competition. It is merging onto a track where every other car has been running for a year, at a speed the new entrant cannot match, with financing the new entrant cannot replicate and relationships the new entrant was never present to build.

This is not a failure of effort or talent. It is a structural inevitability of the sequencing. If Phase One runs long enough before Phase Three begins, the market is not just shaped. It is in motion. And catching a market in motion is fundamentally harder than entering one that has not started yet.

The Sequencing Is The Decision

Almost every state that has launched adult-use cannabis has run this three-phase sequence. The outcome was not determined by the quality of the independent businesses. It was not determined by the licensing rules or the grant programs or the equity provisions. It was determined by one variable: how long Phase One lasted before Phase Three began.

States where Phase One lasted months produced competitive markets. States where it lasted years produced concentrated markets that are now spending tens of millions of dollars trying to reverse structural damage that was baked in during the gap.

Virginia has a bill on the governor’s desk. That bill sets January 1, 2027, as the start date—regardless of whether a single independent business is operational.

But there is an alternative: tie each region of the state’s launch to a simple trigger. Adult-use sales could begin locally when at least one independent cultivator and one independent retailer (with no ownership or operational ties to an existing processor) are certified and selling product.

That is not a delay. It is a launch sequence that makes Phase One as short as possible.

Max Jackson is the founder of Cannabis Wise Guys and specializes in translating between cannabis operations, investment, and public policy. He has provided expert testimony to the Virginia Legislature on preventing market consolidation in emerging cannabis markets. 

Photo courtesy of Max Jackson.

The post Virginia’s Cannabis Sales Legalization Bill Gives An Unfair Head Start To Existing Big Businesses (Op-Ed) appeared first on Marijuana Moment.

View the live link on MarijuanaMoment.net